The Declaration was launched in May 2019 by TBpeople in partnership with the Stop TB Partnership.

End-users (i.e. policy makers; health professionals, including doctors, nurses and educators working in governmental and non-governmental organizations; TB patients) interested in providing comments on the scope of this guideline update are invited to submit their feedback.

The Stop TB Partnership, the Global Fund to Fight AIDS, TB and Malaria and the World Health Organization call for immediate action to implement the commitments made by Head of States and Governments at the UN High-Level Meeting on TB.

The World Health Organization issues a public call for individual patients data on rifampicin-resistant and multidrug-resistant TB treatment outcomes.

WHO Director-General calls for urgent country action to meet UN High-Level Meeting on TB targets in letters to Heads of State.

Advocates request responsible investment in pretomanid promoting transparency and equitable access.

Life without medicines is no party: Activists call on governments across the world to join the #Science4All “party” to make treatment available to all.

Joint statement of WHO Director-General and WHO Civil Society Task Force on accelerating action to end TB.

Safeguarding supply of affordable quality medicines and diagnostics in context of risky transitions and co-financing.

IAS 2019 symposium: Expert speakers to discuss how to reform the medical research and development (R&D) model and how to foster a more effective TB response.